{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:39:15Z","timestamp":1783906755735,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":2331,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.4103\/0255-0857.148400","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T10:11:48Z","timestamp":1420193508000},"page":"96-100","source":"Crossref","is-referenced-by-count":6,"title":["Correlation between two chemiluminescence based assays for quantification of hepatitis B surface antigen in patients with chronic hepatitis B infection"],"prefix":"10.1016","volume":"33","author":[{"given":"E","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MK","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SK","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4103\/0255-0857.148400_bib1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4103\/0255-0857.148400_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of Hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay","volume":"115","author":"Deguchi","year":"2004","journal-title":"J Virol Methods"},{"key":"10.4103\/0255-0857.148400_bib3","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep.24364","article-title":"Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review","volume":"53","author":"Liaw","year":"2011","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.148400_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.21282","article-title":"Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B","volume":"44","author":"Wursthorn","year":"2006","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.148400_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","article-title":"Serum Hepatitis B surface Antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers","volume":"51","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.148400_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jmv.23461","article-title":"Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-na\u00efve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma","volume":"85","author":"Wang","year":"2013","journal-title":"J Med Virol"},{"key":"10.4103\/0255-0857.148400_bib7","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s10620-008-0263-5","article-title":"Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment","volume":"53","author":"Ozaras","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.4103\/0255-0857.148400_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0255-0857.96664","article-title":"Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: A cross-sectional study","volume":"30","author":"Gupta","year":"2012","journal-title":"Indian J Med Microbiol"},{"key":"10.4103\/0255-0857.148400_bib9","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.3748\/wjg.v18.i39.5570","article-title":"Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients","volume":"18","author":"Orito","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.4103\/0255-0857.148400_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"key":"10.4103\/0255-0857.148400_bib11","article-title":"Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients","author":"Wang","year":"2013","journal-title":"J Formos Med Assoc."},{"key":"10.4103\/0255-0857.148400_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/hep.22760","article-title":"Hepatitis virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B","volume":"49","author":"Brunetto","year":"2009","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.148400_bib13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.23844","article-title":"Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment Hepatitis B surface Antigen decline","volume":"52","author":"Sonneveld","year":"2010","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.148400_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: Update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.148400_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.4103\/0255-0857.148400_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcv.2012.04.010","article-title":"The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays","volume":"54","author":"Verheyen","year":"2012","journal-title":"J Clin Virol"},{"key":"10.4103\/0255-0857.148400_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jmv.21706","article-title":"Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays","volume":"82","author":"Louisirirotchanakul","year":"2010","journal-title":"J Med Virol"},{"key":"10.4103\/0255-0857.148400_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jvh.12044","article-title":"Quantification of hepatitis B surface antigen and E antigen: Correlation between Elecsys and architect assays","volume":"20","author":"Zhou","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.4103\/0255-0857.148400_bib19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1309\/AJCP8QDN7NAUXJFJ","article-title":"Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: Two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay","volume":"137","author":"Park","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.4103\/0255-0857.148400_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1743-422X-5-156","article-title":"An overview of molecular epidemiology of hepatitis B virus (HBV) in India","volume":"5","author":"Datta","year":"2008","journal-title":"Virol J"},{"key":"10.4103\/0255-0857.148400_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jhep.2010.01.014","article-title":"Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective","volume":"52","author":"Jaroszewicz","year":"2010","journal-title":"J Hepatol"},{"key":"10.4103\/0255-0857.148400_bib22","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1537-2995.2004.04055.x","article-title":"Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: Implications for future HBV screening policy","volume":"44","author":"Kuhns","year":"2004","journal-title":"Transfusion"},{"key":"10.4103\/0255-0857.148400_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jmv.20262","article-title":"Quantitative detection of hepatitis B surface antigen by chemiluminiscent microparticle immunoassay during lamivudine treatment","volume":"75","author":"Kohmoto","year":"2005","journal-title":"J Med Virol"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721003194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721003194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:23:06Z","timestamp":1621516986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721003194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0255085721003194"],"URL":"https:\/\/doi.org\/10.4103\/0255-0857.148400","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}